1. Home
  2. ECVT vs BHVN Comparison

ECVT vs BHVN Comparison

Compare ECVT & BHVN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Ecovyst Inc.

ECVT

Ecovyst Inc.

HOLD

Current Price

$8.55

Market Cap

926.8M

Sector

Industrials

ML Signal

HOLD

Logo Biohaven Ltd.

BHVN

Biohaven Ltd.

HOLD

Current Price

$10.54

Market Cap

1.1B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ECVT
BHVN
Founded
1935
2013
Country
United States
United States
Employees
N/A
N/A
Industry
Major Chemicals
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
926.8M
1.1B
IPO Year
2017
2017

Fundamental Metrics

Financial Performance
Metric
ECVT
BHVN
Price
$8.55
$10.54
Analyst Decision
Strong Buy
Buy
Analyst Count
5
16
Target Price
$11.70
$29.79
AVG Volume (30 Days)
1.4M
4.4M
Earning Date
11-04-2025
11-10-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$779,147,000.00
N/A
Revenue This Year
$8.10
N/A
Revenue Next Year
$1.69
$2,219.74
P/E Ratio
N/A
N/A
Revenue Growth
25.22
N/A
52 Week Low
$5.24
$7.48
52 Week High
$9.69
$45.87

Technical Indicators

Market Signals
Indicator
ECVT
BHVN
Relative Strength Index (RSI) 47.79 49.90
Support Level $8.47 $8.29
Resistance Level $8.56 $10.18
Average True Range (ATR) 0.32 0.76
MACD -0.01 0.34
Stochastic Oscillator 35.51 90.59

Price Performance

Historical Comparison
ECVT
BHVN

About ECVT Ecovyst Inc.

Ecovyst Inc is an integrated and provider of materials, specialty catalysts and services. Its products contribute to lower emissions and cleaner air, higher fuel efficiency and cleaner fuels, and key enablers to advance transition to clean energy. The company has two reporting segments: Ecoservices and Advanced Materials & Catalysts. Ecoservices provides sulfuric acid recycling to the North American refining industry for the production of alkylate and provides on-purpose virgin sulfuric acid for water treatment, mining, and industrial applications. Maximum revenue is generated from Ecoservices segment.

About BHVN Biohaven Ltd.

Biohaven Ltd is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of life-changing treatments in key therapeutic areas, including immunology, neuroscience, and oncology. Its product pipeline includes Glutamate, Myostatin, Ion channels, Inflammation & Immunology, and Oncology. The company's products target diseases such as neuromuscular and metabolic diseases, antibody-drug conjugates for cancer, obsessive-compulsive disorder, and others.

Share on Social Networks: